Dr. Kalliopi Vallianou | Nephrology | Best Researcher Award

Dr. Kalliopi Vallianou | Nephrology | Nephrologist at Laiko General Hospital of Athens | Greece

Dr. Kalliopi Vallianou is an accomplished medical professional and researcher specializing in Nephrology and Transplantation Medicine, currently serving as a Consultant in Nephrology at the Clinic of Nephrology and Renal Transplantation, “Laiko” General Hospital of Athens. Dr. Kalliopi Vallianou earned her Medical Degree from the Aristotle University of Thessaloniki, followed by specialized clinical training in Internal Medicine and Nephrology across leading healthcare institutions in Greece. She has obtained both Greek and European Specialties in Nephrology, and further advanced her credentials with a European Fellowship in Transplantation Medicine (EBSQ). In addition, Dr. Kalliopi Vallianou is pursuing a Ph.D. in the field of Nephrology at the National and Kapodistrian University of Athens, focusing on “Physical activity and arterial stiffness in adolescents and young adults with kidney transplantation.” Her academic achievements are complemented by a Master’s degree in Epidemiology and Research Methodology in biomedical sciences and public health. Professionally, Dr. Kalliopi Vallianou has extensive experience managing complex renal disorders, transplantation cases, and post-operative care for kidney transplant recipients. Her research interests encompass transplant immunology, glomerular diseases, renal replacement therapy, and long-term outcomes of organ transplantation. She possesses exceptional research and analytical skills, including clinical data interpretation, biomarker analysis, and evidence-based nephrology practices. Dr. Kalliopi Vallianou is an active member of multiple professional societies, including the Hellenic Society of Nephrology, the European Renal Association (ERA-EDTA), and the European Society for Organ Transplantation (ESOT). She has received notable recognition for her clinical contributions and research presentations at international medical congresses. Her numerous peer-reviewed publications in high-impact journals, such as the Journal of Clinical Medicine and BMC Nephrology, highlight her commitment to improving transplantation outcomes and advancing medical knowledge. Through her ongoing dedication to research, teaching, and clinical excellence, Dr. Kalliopi Vallianou continues to be a driving force in modern nephrology and transplantation medicine, exemplifying the balance between compassionate care and scientific innovation.

Profile: Google Scholar

Featured Publications

  1. Vallianou, K., Marinaki, S., Skalioti, C., Lionaki, S., Darema, M., & Boletis, J. N. (2021). Therapeutic options for recurrence of primary focal segmental glomerulonephritis (FSGS) in the renal allograft: single-center experience. Journal of Clinical Medicine, 10(3), 373. Cited by 14.

  2. Vallianou, K., Skalioti, C., Liapis, G., Boletis, J. N., & Marinaki, S. (2020). A case report of hypocomplementemic urticarial vasculitis presenting with membranoproliferative glomerulonephritis. BMC Nephrology, 21(1), 351. Cited by 14.

  3. Korogiannou, M., Vallianou, K., Xagas, E., Rokka, E., Soukouli, I., & Boletis, I. N. (2023). Disease course, management and outcomes in kidney transplant recipients with SARS-CoV-2 infection during the Omicron-variant wave: a single-center experience. Vaccines, 11(3), 632. Cited by 8.

  4. Marinaki, S., Tsiakas, S., Skalioti, C., Kapsia, E., Lionaki, S., & Vallianou, K. (2022). Pregnancy in women with preexisting glomerular diseases: A single-center experience. Frontiers in Medicine, 9, 801144. Cited by 5.

  5. Lionaki, S., Liapis, G., Vallianou, K., Vergadis, C., & Boletis, I. (2020). The various forms of nephrotic syndrome in a patient with systemic lupus erythematosus. Case Reports in Nephrology, 2020(1), 7869216. Cited by 5.

  6. Marinaki, S., Vallianou, K., Melexopoulou, C., Lionaki, S., Darema, M., & Boletis, I. N. (2021). The changing landscape of Pneumocystis jiroveci infection in kidney transplant recipients: single-center experience of late-onset pneumocystis pneumonia. Transplantation Proceedings, 53(5), 1576–1582. Cited by 4.

  7. Marinaki, S., Vittoraki, A., Tsiakas, S., Kofotolios, I., Darema, M., & Vallianou, K. (2023). Clinical outcome of kidney transplant recipients with C1q-binding de novo donor specific antibodies: A single-center experience. Journal of Clinical Medicine, 12(13), 4475. Cited by 1.

 

Kalliopi Vallianou | Nephrology | Best Researcher Award

You May Also Like